Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Gastrointestinal » Inflammatory Bowel Disease 14. June 2024
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2565  Previews Next
   
   Articles 1 - 20 / 51295  
   
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Lancet Gastroenterol Hepatol
Chen R, Zhang S.
PMID: 38870967 [PubMed - indexed for MEDLINE]


Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial - Authors' reply.
Lancet Gastroenterol Hepatol
Noor NM, Lee JC, Bond S, Parkes M.
PMID: 38870966 [PubMed - indexed for MEDLINE]


Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Lancet Gastroenterol Hepatol
Borkar V, Lunagariya Y, Chopra S, Sasikumar D, Ingle M.
PMID: 38870965 [PubMed - indexed for MEDLINE]


Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Lancet Gastroenterol Hepatol
Satsangi J, Nowak J, Kalla R, Colombel JF.
PMID: 38870964 [PubMed - indexed for MEDLINE]


Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Lancet Gastroenterol Hepatol
Bourgonje AR, Visschedijk MC, Festen EAM, Weersma RK, Dijkstra G.
PMID: 38870963 [PubMed - indexed for MEDLINE]


Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.
Int J Colorectal Dis
Rodríguez-Lago I, Aduna M, Ramírez de la Piscina P, Merino O, Carrascosa J, Higuera R, Maíz A, Zapata E, Cabriada JL, Barreiro-de Acosta M.
PMID: 38871954 [PubMed - indexed for MEDLINE]


Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis.
J Crohns Colitis
Narula N, Hamam H, Liu J, Wong ECL, Marshall JK, Jairath V, Hanauer SB, Reinisch W, Dulai PS.
PMID: 38869911 [PubMed - as supplied by publisher]


Risk Factors for Persistent Postoperative Opioid Use After Surgery for IBD: An Observational Cohort Study.
Dis Colon Rectum
Lin VA, Hasselager RP, Fransgaard T, Gögenur I.
PMID: 38869466 [PubMed - indexed for MEDLINE]


Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Program.
J Crohns Colitis
Danese S, Dignass A, Matsuoka K, Ferrante M, Long M, Redondo I, Moses R, Maier S, Hunter Gibble T, Morris N, Milch C, Abreu MT.
PMID: 38869019 [PubMed - as supplied by publisher]


No causal relationship between glucose and inflammatory bowel disease: a bidirectional two-sample mendelian randomization study.
BMC Med Genomics
Cen J, Chen K, Ni Z, Dai Q, Lu W, Tao H, Peng L.
PMID: 38867275 [PubMed - indexed for MEDLINE]


Autophagy: A potential target for natural products in the treatment of ulcerative colitis.
Biomed Pharmacother
Zhang W, Zou M, Fu J, Xu Y, Zhu Y.
PMID: 38865850 [PubMed - as supplied by publisher]


Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study.
Inflamm Bowel Dis
Bertani L, Antonioli L, Fornili M, D'Antongiovanni V, Ceccarelli L, Carmisciano L, Benvenuti L, Mumolo MG, Bottari A, Pardi V, Baiano Svizzero G, Baglietto L, De Bortoli N, Bellini M, Fornai M, Costa F.
PMID: 38864707 [PubMed - as supplied by publisher]


Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease.
Aliment Pharmacol Ther
Attauabi M, Steenholdt C, Poulsen A, Gubatan J, Burisch J, Haagen Nielsen O, Seidelin JB.
PMID: 38863153 [PubMed - as supplied by publisher]


Reversal Surgery for Split Stoma with Peristomal Incision is Associated with Improved Postoperative Outcome in Patients with Crohn's Disease.
J Invest Surg
Wang S, Du K, Duan M, Xu Y, Guo Z, Gong J, Zhu W, Li Y.
PMID: 38862416 [PubMed - indexed for MEDLINE]


The Efficacy of Combination Therapy with Ustekinumab and Budesonide for Crohn's Disease: A Randomized Controlled Trial.
Inflamm Intest Dis
Moroi R, Hishinuma K, Sugawara Y, Nochioka K, Shimoyama Y, Naito T, Shiga H, Kakuta Y, Kinouchi Y, Tsuji I, Masamune A.
PMID: 38860189 [PubMed]


Molecular targets associated with ulcerative colitis and the benefits of atractylenolides-based therapy.
Front Pharmacol
Qian H, Ye Z, Hu Y, Wu M, Chen L, Li L, Hu Z, Zhao Q, Zhang C, Yang M, Xudong W, Ye Q, Qin K.
PMID: 38860174 [PubMed]


Short-term outcomes of surgical treatment for primary ileocaecal Crohn's disease: Results of the Crohn's(urg) study, a multicentre, retrospective, comparative analysis between inflammatory and complicated phenotypes.
Colorectal Dis
Avellaneda N, Pellino G, Maroli A, Tottrup A, Bislenghi G, Colpaert J, D'Hoore A, Carvello M, Giorgi L, Juachon P, Harslřf S, de Buck Van Overstraeten A, Olivera PA, Gomez J, Holubar SD, Naranjo EL, Steele SR, Merchea A, Shaker A, Gallostra MM, Kraft M, Kotze PG, Maruyama BY, Wexner SD, Garoufalia Z, Chen Z, Hahnloser D, Rrupa D, Buskens C, Haanappel A, Warusavitarne J, Williams KJ, Christensen P, Wolthuis A, Potolicchio A, Spinelli A.
PMID: 38858815 [PubMed - as supplied by publisher]


Sources of diagnostic delay for people with Crohn's disease and ulcerative colitis: Qualitative research study.
PLoS One
AWARE-IBD Diagnostic Delay Working Group.
PMID: 38857292 [PubMed - indexed for MEDLINE]


Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China.
Gastroenterol Rep (Oxf)
Liu X, Li H, Tian F, Xie Y, Zhang X, Zhi M, Zhang M, Song X, Guo H, Li X, Liang J, Shen J, Li Y.
PMID: 38855349 [PubMed]


Meta-analysis of etrolizumab versus placebo in ulcerative colitis: safety and efficacy outcomes.
Therap Adv Gastroenterol
Zhang R, Jia Z, Piao Y.
PMID: 38855341 [PubMed]


   
   Articles 1 - 20 / 51295    Page 1 of 2565  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1